please Wait...
CRS (Cytoreductive Surgery) and HIPEC (Hyperthermic Intraperitoneal Chemotherapy) is a combined surgical and chemotherapy treatment approach primarily used for certain types of advanced abdominal cancers, including peritoneal carcinomatosis and pseudomyxoma peritonei. It's an aggressive treatment strategy aimed at removing visible tumor masses from the abdominal cavity and then delivering heated chemotherapy directly into the abdominal cavity to target any remaining cancer cells.
CRS (Cytoreductive Surgery) and HIPEC (Hyperthermic Intraperitoneal Chemotherapy) are combined treatments used to manage certain advanced abdominal cancers that have spread within the peritoneal cavity. This approach is commonly employed for cancers originating in the abdominal organs like the appendix, colon, stomach, ovaries, and certain forms of mesothelioma.
CRS (Cytoreductive Surgery) and HIPEC (Hyperthermic Intraperitoneal Chemotherapy) are not cancers themselves, but rather treatments for advanced abdominal cancers that have spread within the peritoneal cavity.
